Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05827081
Title Phase IIIb Study of Ribociclib + ET in Early Breast Cancer (Adjuvant WIDER)
Acronym Adjuvant WIDER
Recruitment Suspended
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.